Covid-19 Pandemic and Pancreatic Surgery in Italy (PanCOVID)

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Pancreatic Cancer

Treatments: Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04380766

FPGemelliIRCCS

Details and patient eligibility

About

Pancreatic cancer (PC) is recognized as one of the most challenging tumors to deal with and it is still characterized by a poor long-term prognosis. However, treatment of PC in high-volume centers with the support of a multidisciplinary approach has widely demonstrated improvement both in terms of short- and long-term outcomes. The recent worldwide spread of Covid-19 pandemic significantly affected the healthcare systems of most countries in the world, particularly in red areas such as Italy, with more than 100.000 cases in a two-month time lapse. This inevitably reflected in a reorganization of hospital activities, including the diagnostic and therapeutic pathways for PC treatment. With the aim of giving an objective and real representation of the impact of Covid-19 on PC treatment, the investigator here propose a multicenter Italian observational study comparing a 6-month period before and during the Covid-19 pandemic. Only high-volume centers will be involved in the study. A comparison between the general, clinical, endoscopic and surgical outcomes will be performed by means of a global and month-by-month analysis between the two study periods.

Enrollment: 730 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

all patients with a diagnosis of pancreatic cancer referred to one of the centers involved in the study during the two study periods

Exclusion criteria

• patients under the age of 18
• inability to give informed consent

Trial design

730 participants in 2 patient groups

Pre-COVID

Description:

All patients with pancreatic cancer diagnosis before COVID-19 pandemic

Treatment:

Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer

COVID

Description:

All patients with pancreatic cancer diagnosis during COVID-19 pandemic

Treatment:

Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer